郭正, 赵之栋, 高划一, 李众利. 关节腔注射负载Dickkopf-3的温敏羟丁基壳聚糖水凝胶对大鼠骨关节炎的影响[J]. 解放军医学院学报, 2023, 44(7): 787-793. DOI: 10.12435/j.issn.2095-5227.2023.023
引用本文: 郭正, 赵之栋, 高划一, 李众利. 关节腔注射负载Dickkopf-3的温敏羟丁基壳聚糖水凝胶对大鼠骨关节炎的影响[J]. 解放军医学院学报, 2023, 44(7): 787-793. DOI: 10.12435/j.issn.2095-5227.2023.023
GUO Zheng, ZHAO Zhidong, GAO Huayi, LI Zhongli. Effects of intra-articular injection of Dickkopf-3-loaded thermo-sensitive hydroxybutyl chitosan hydrogel on osteoarthritis in rats[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(7): 787-793. DOI: 10.12435/j.issn.2095-5227.2023.023
Citation: GUO Zheng, ZHAO Zhidong, GAO Huayi, LI Zhongli. Effects of intra-articular injection of Dickkopf-3-loaded thermo-sensitive hydroxybutyl chitosan hydrogel on osteoarthritis in rats[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(7): 787-793. DOI: 10.12435/j.issn.2095-5227.2023.023

关节腔注射负载Dickkopf-3的温敏羟丁基壳聚糖水凝胶对大鼠骨关节炎的影响

Effects of intra-articular injection of Dickkopf-3-loaded thermo-sensitive hydroxybutyl chitosan hydrogel on osteoarthritis in rats

  • 摘要:
      背景  Dickkopf相关蛋白3(Dickkopf-3,DKK3)具有治疗骨关节炎(osteoarthritis,OA)的潜力,羟丁基壳聚糖(hydroxybutyl chitosan,HBC)温敏水凝胶是一种新型药物载体。
      目的  探讨负载DKK3的HBC(DKK3-loaded HBC)水凝胶对OA大鼠的影响。
      方法  制备DKK3-loaded HBC,通过恒温水浴测定凝胶时间,酶联免疫吸附实验计算体外释放曲线,细胞毒性实验验证安全性。将24只大鼠随机均匀分为假手术组、OA模型组、OA + DKK3组、OA + DKK3-loaded HBC组,每组6只。使用前交叉韧带离断法造模后,不同组别大鼠分别关节腔注射磷酸盐缓冲溶液、DKK3或DKK3-loaded HBC干预。步态分析后分离大鼠膝关节,进行显微计算机断层扫描评估骨质改变,苏木精和伊红染色以及免疫组化染色评估软骨改变。
      结果  DKK3-loaded HBC溶液在37℃条件下10 s内形成水凝胶,DKK3在24 h内迅速释放并持续超过168 h。DKK3和HBC浸取液对软骨细胞活力没有显著影响。与OA模型组相比,OA + DKK3-loaded HBC组大鼠的步速、步幅、后爪与地面接触时间提高(P均<0.05),骨和软骨的完整性提高,软骨基质的损失和软骨基质酶的表达减少(P均<0.05)。
      结论  HBC具有良好的药物缓释能力,关节腔注射DKK3-loaded HBC可能通过降低软骨基质酶的表达延缓大鼠OA的进展,改善疼痛和运动能力。

     

    Abstract:
      Background  Dickkopf-3 (DKK3) has possibilities for the treatment of osteoarthritis (OA) and hydroxybutyl chitosan (HBC) thermo-sensitive hydrogel is a promising drug vehicle.
      Objective  To investigate the impact of DKK3-loaded thermo-sensitive HBC hydrogel on rats with OA.
      Methods  DKK3-loaded HBC was prepared, whose gel formation time, cumulative release, and safety were determined by constant temperature water bath, enzyme-linked immunosorbent and Cell Counting Kit-8 assays. Then 24 rats were randomly divided into sham group, OA Model group, OA + DKK3 group, OA + DKK3-loaded HBC group, with 6 rats in each group. After model establishment by anterior cruciate ligament disconnection, rats were intra-articular injected with phosphate buffered solution, DKK3 or DKK3-loaded HBC respectively. After gait analysis, the knee joints of rats were isolated. Bone changes were evaluated by micro computed tomography, and cartilage changes were evaluated by haematoxylin and eosin staining and immunohistochemical staining.
      Results  DKK3-loaded HBC hydrogel could be created in 10 s at 37℃, and DKK3 was released rapidly within 24 h and sustained over 168 h. DKK3 and HBC extraction solutions had extremely slight cytotoxicity and no significant effect on chondrocyte viability. Compared with the OA Model group, the OA + DKK3 loaded HBC group showed an increase in speed, stride length, and single stance (all P<0.05), improved bone and cartilage integrity, decreased cartilage matrix loss and expression of cartilage matrix decomposing enzymes (all P<0.05).
      Conclusion  HBC shows drug sustained release behavior, and the intra-articular injection of DKK3-loaded HBC can slow the progression of OA in rats and improve pain and locomotor performance by reducing the expression of cartilage matrix decomposing enzyme.

     

/

返回文章
返回